tacrolimus has been researched along with Dementia--Vascular* in 4 studies
4 other study(ies) available for tacrolimus and Dementia--Vascular
| Article | Year |
|---|---|
Leukoencephalopathy with cerebral hemorrhage following acute pancreatitis due to tacrolimus in a case of allogeneic peripheral blood stem cell transplantation.
Topics: Acute Disease; Aged; Cerebral Hemorrhage; Dementia, Vascular; Endothelial Cells; Humans; Male; Neurotoxicity Syndromes; Pancreatitis; Peripheral Blood Stem Cell Transplantation; Tacrolimus; Transplantation, Homologous | 2006 |
FK 506-induced fulminant leukoencephalopathy after kidney transplantation: case report.
Topics: Adolescent; Brain; Brain Edema; Cerebral Infarction; Dementia, Vascular; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Magnetic Resonance Imaging; Male; Postoperative Complications; Tacrolimus | 2002 |
FK506 ameliorates the discrimination learning impairment due to preventing the rarefaction of white matter induced by chronic cerebral hypoperfusion in rats.
We examined the effects of the immunosuppressant tacrolimus (FK506) on the discrimination learning impairment induced by chronic cerebral hypoperfusion in rats. Chronic cerebral hypoperfusion was prepared by permanent ligation of bilateral common carotid arteries for male Wistar rats aged 9 weeks. FK506 (0.05 mg/kg, s.c.) recovered the learning impairment and also prevented the rarefaction of white matter and striatal neuronal cell damage. Our findings suggest that FK506 ameliorates the learning impairment mainly due to preventing neuropathological alterations. Topics: Animals; Brain; Cerebrovascular Circulation; Chronic Disease; Corpus Callosum; Dementia, Vascular; Frontal Lobe; Hypoxia-Ischemia, Brain; Immunosuppressive Agents; Learning Disabilities; Male; Neostriatum; Nerve Degeneration; Nerve Fibers, Myelinated; Rats; Rats, Wistar; Recovery of Function; Tacrolimus | 2001 |
FK506-induced intractable leukoencephalopathy following allogeneic bone marrow transplantation.
FK506-related leukoencephalopathy has been reported to be reversible and readily treated by discontinuation or reduction of FK506. We describe two pediatric cases of FK506-related leukoencephalopathy following allogeneic bone marrow transplantation, which could not be readily controlled. These cases show that FK506-related leukoencephalopathy is not always reversible, and patients may develop epilepsy. Bone Marrow Transplantation (2000) 25, 331-334. Topics: Acute Disease; Adolescent; Child, Preschool; Cyclosporine; Dementia, Vascular; Electroencephalography; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Magnetic Resonance Imaging; Male; Seizures; Tacrolimus | 2000 |